- Markets
- Healthcare
- MAXHEALTH
MAXHEALTH
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Max Healthcare Institute Updates On Matter Against Competition Commission Of India
March 14 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
UPDATES ON MATTER AGAINST COMPETITION COMMISSION OF INDIA
WITHDRAWS WRIT PETITION CHALLENGING ORDER OF CCI
Source text: ID:nBSE9bhFwW
Further company coverage: MAXE.NS
(([email protected];;))
March 14 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
UPDATES ON MATTER AGAINST COMPETITION COMMISSION OF INDIA
WITHDRAWS WRIT PETITION CHALLENGING ORDER OF CCI
Source text: ID:nBSE9bhFwW
Further company coverage: MAXE.NS
(([email protected];;))
Max Healthcare Institute To Enter Into Agreement With Bharat Prakritik Chikitsa Mission
March 12 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
TO ENTER INTO AGREEMENT WITH BHARAT PRAKRITIK CHIKITSA MISSION
CONSTRUCTION OF HOSPITAL PREMISES EXPECTED TO BE COMPLETED IN NEXT 3-4 YRS
Source text: ID:nBSE7FVq1s
Further company coverage: MAXE.NS
(([email protected];;))
March 12 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
TO ENTER INTO AGREEMENT WITH BHARAT PRAKRITIK CHIKITSA MISSION
CONSTRUCTION OF HOSPITAL PREMISES EXPECTED TO BE COMPLETED IN NEXT 3-4 YRS
Source text: ID:nBSE7FVq1s
Further company coverage: MAXE.NS
(([email protected];;))
Max Healthcare Institute Unit Got Tax Order For Penalty Of 61.6 Million Rupees
July 16 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MAX HEALTHCARE INSTITUTE - UNIT GOT TAX ORDER FOR PENALTY OF 61.6 MILLION RUPEES
Source text for Eikon: ID:nNSE5Z1LfJ
Further company coverage: MAXE.NS
(([email protected];))
July 16 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MAX HEALTHCARE INSTITUTE - UNIT GOT TAX ORDER FOR PENALTY OF 61.6 MILLION RUPEES
Source text for Eikon: ID:nNSE5Z1LfJ
Further company coverage: MAXE.NS
(([email protected];))
Max Healthcare Institute Q4 Consol Profit 2.52 Billion Rupees Lseg Ibes Profit Est. 3.62 Billion Rupees
May 22 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
Q4 CONSOL PROFIT 2.52 BILLION RUPEES; LSEG IBES PROFIT EST. 3.62 BILLION RUPEES
APPROVED AN OVERALL SPEND OF UPTO 10.38 BILLION RUPEES TOWARDS CONSTRUCTION OF GURUGRAM HOSPITAL
Q4 CONSOL REVENUE FROM OPERATIONS 14.23 BILLION RUPEES; LSEG IBES EST. 18.04 BILLION RUPEES
YEAR AGO Q4 CONSOL PROFIT 2.51 BILLION RUPEES; REVENUE 12.15 BILLION RUPEES
APPROVED OVERALL SPEND OF UPTO 3.76 BILLION RUPEES TOWARD EXPANSION OF MOHALI HOSPITAL
DIVIDEND OF 1.5 RUPEES PER SHR
Source text for Eikon: ID:nBSEc0tmzz
Further company coverage: MAXE.NS
(([email protected];))
May 22 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
Q4 CONSOL PROFIT 2.52 BILLION RUPEES; LSEG IBES PROFIT EST. 3.62 BILLION RUPEES
APPROVED AN OVERALL SPEND OF UPTO 10.38 BILLION RUPEES TOWARDS CONSTRUCTION OF GURUGRAM HOSPITAL
Q4 CONSOL REVENUE FROM OPERATIONS 14.23 BILLION RUPEES; LSEG IBES EST. 18.04 BILLION RUPEES
YEAR AGO Q4 CONSOL PROFIT 2.51 BILLION RUPEES; REVENUE 12.15 BILLION RUPEES
APPROVED OVERALL SPEND OF UPTO 3.76 BILLION RUPEES TOWARD EXPANSION OF MOHALI HOSPITAL
DIVIDEND OF 1.5 RUPEES PER SHR
Source text for Eikon: ID:nBSEc0tmzz
Further company coverage: MAXE.NS
(([email protected];))
KKR to buy India's Healthium Medtech at $839 mln valuation, sources say
Repeats for wider distribution with no changes to text
MUMBAI/BENGALURU, May 6 (Reuters) - Global investment firm KKR KKR.N will buy Indian medical devices maker Healthium Medtech HEAT.NS from UK-based Apax Partners in a deal that three sources with direct knowledge of the matter say is valued at 70 billion rupees ($838.60 million).
Healthium and Apax did not immediately respond to Reuters' requests seeking comment, while KKR declined to comment.
KKR will acquire Healthium through a special purpose vehicle - owned by KKR-managed funds - that will have a controlling interest in Healthium group, including Healthium Medtech, the three companies said in a statement.
The acquisition marks KKR's latest investment in the Indian healthcare sector, with the firm already holding stakes in Indian drugmaker J B Chemicals and Pharmaceuticals JBCH.NS, hospital chain operator Max Healthcare MAXE.NS and generic injectables maker Gland Pharma GLAD.NS.
Private equity firm Apax bought Healthium, which is involved in the manufacturing of products used in surgical, post-surgical, and chronic care procedures, in 2018.
($1 = 83.4725 Indian rupees)
(Reporting by Kashish Tandon in Bengaluru, M. Sriram in Mumbai, Kane Wu in Hong Kong; Editing by Janane Venkatraman )
(([email protected]; 8800437922;))
Repeats for wider distribution with no changes to text
MUMBAI/BENGALURU, May 6 (Reuters) - Global investment firm KKR KKR.N will buy Indian medical devices maker Healthium Medtech HEAT.NS from UK-based Apax Partners in a deal that three sources with direct knowledge of the matter say is valued at 70 billion rupees ($838.60 million).
Healthium and Apax did not immediately respond to Reuters' requests seeking comment, while KKR declined to comment.
KKR will acquire Healthium through a special purpose vehicle - owned by KKR-managed funds - that will have a controlling interest in Healthium group, including Healthium Medtech, the three companies said in a statement.
The acquisition marks KKR's latest investment in the Indian healthcare sector, with the firm already holding stakes in Indian drugmaker J B Chemicals and Pharmaceuticals JBCH.NS, hospital chain operator Max Healthcare MAXE.NS and generic injectables maker Gland Pharma GLAD.NS.
Private equity firm Apax bought Healthium, which is involved in the manufacturing of products used in surgical, post-surgical, and chronic care procedures, in 2018.
($1 = 83.4725 Indian rupees)
(Reporting by Kashish Tandon in Bengaluru, M. Sriram in Mumbai, Kane Wu in Hong Kong; Editing by Janane Venkatraman )
(([email protected]; 8800437922;))
Max Healthcare Institute Says Arbitration Proceedings With Touch Healthcare Discontinued
March 12 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
CO, TOUCH HEALTHCARE AND OTHERS HAVE ENTERED INTO AN AGREEMENT
AGREEMENT IN RESPECT OF THE ONGOING ARBITRATION PROCEEDINGS BETWEEN THE PARTIES
PURSUANT TO AGREEMENT SAID ARBITRATION PROCEEDINGS HAVE BEEN DISCONTINUED
Further company coverage: MAXE.NS
(([email protected];))
March 12 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
CO, TOUCH HEALTHCARE AND OTHERS HAVE ENTERED INTO AN AGREEMENT
AGREEMENT IN RESPECT OF THE ONGOING ARBITRATION PROCEEDINGS BETWEEN THE PARTIES
PURSUANT TO AGREEMENT SAID ARBITRATION PROCEEDINGS HAVE BEEN DISCONTINUED
Further company coverage: MAXE.NS
(([email protected];))
Max Healthcare Institute Q3 Consol Profit 2.89 Bln Rupees
Jan 31 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
APPROVED TO ACQUIRE ADDITIONAL EQUITY STAKE OF 3.6% IN SANDHYA HYDRO POWER PROJECTS BALARGHA
Q3 CONSOL PROFIT 2.89 BILLION RUPEES; LSEG IBES EST. 3.32 BILLION RUPEES
Q3 CONSOL REVENUE FROM OPERATIONS 13.35 BILLION RUPEES
YEAR AGO Q3 CONSOL PROFIT 2.22 BILLION RUPEES; REVENUE 11.42 BILLION RUPEES
APPROVED TO ACQUIRE ADDITIONAL EQUITY STAKE OF 3.6% IN SANDHYA HYDRO POWER PROJECTS BALARGHA
COST OF ACQUISITION AT 8.5 MILLION RUPEES
Source text for Eikon: ID:nBSE1y5fJK
Further company coverage: MAXE.NS
(([email protected];))
Jan 31 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
APPROVED TO ACQUIRE ADDITIONAL EQUITY STAKE OF 3.6% IN SANDHYA HYDRO POWER PROJECTS BALARGHA
Q3 CONSOL PROFIT 2.89 BILLION RUPEES; LSEG IBES EST. 3.32 BILLION RUPEES
Q3 CONSOL REVENUE FROM OPERATIONS 13.35 BILLION RUPEES
YEAR AGO Q3 CONSOL PROFIT 2.22 BILLION RUPEES; REVENUE 11.42 BILLION RUPEES
APPROVED TO ACQUIRE ADDITIONAL EQUITY STAKE OF 3.6% IN SANDHYA HYDRO POWER PROJECTS BALARGHA
COST OF ACQUISITION AT 8.5 MILLION RUPEES
Source text for Eikon: ID:nBSE1y5fJK
Further company coverage: MAXE.NS
(([email protected];))
Max Healthcare Institute- To Buy Sahara Hospital, Lucknow For 9.40 Bln Rupees
Dec 8 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MAX HEALTHCARE INSTITUTE LTD- ENTERS INTO A SHARE PURCHASE AGREEMENT FOR ACQUISITION OF 550 BEDDED SAHARA HOSPITAL, LUCKNOW
MAX HEALTHCARE INSTITUTE LTD- DEAL FOR ENTERPRISE VALUE OF 9.4 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: MAXE.NS
(([email protected];))
Dec 8 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MAX HEALTHCARE INSTITUTE LTD- ENTERS INTO A SHARE PURCHASE AGREEMENT FOR ACQUISITION OF 550 BEDDED SAHARA HOSPITAL, LUCKNOW
MAX HEALTHCARE INSTITUTE LTD- DEAL FOR ENTERPRISE VALUE OF 9.4 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: MAXE.NS
(([email protected];))
India's Max Healthcare Institute Sept-Quarter Consol Profit at 2.77 Billion Rupees
Nov 6 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
SEPT-QUARTER CONSOL PROFIT 2.77 BILLION RUPEES; LSEG IBES EST. 3.24 BILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 13.63 BILLION RUPEES
YEAR AGO SEPT-QUARTER CONSOL PROFIT 4.57 BILLION RUPEES; REVENUE 11.39 BILLION RUPEES
Source text for Eikon: ID:nBSE2KwTy0
Further company coverage: MAXE.NS
(([email protected];))
Nov 6 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
SEPT-QUARTER CONSOL PROFIT 2.77 BILLION RUPEES; LSEG IBES EST. 3.24 BILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 13.63 BILLION RUPEES
YEAR AGO SEPT-QUARTER CONSOL PROFIT 4.57 BILLION RUPEES; REVENUE 11.39 BILLION RUPEES
Source text for Eikon: ID:nBSE2KwTy0
Further company coverage: MAXE.NS
(([email protected];))
India's Max Healthcare Institute June-Quarter Consol Profit Rises
Aug 7 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
INDIA'S MAX HEALTHCARE INSTITUTE JUNE-QUARTER CONSOL PROFIT 2.4 BILLION RUPEES VERSUS 1.73 BILLION RUPEES
MAX HEALTHCARE INSTITUTE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 12.85 BILLION RUPEES VERSUS 10.67 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: MAXE.NS
(([email protected];))
Aug 7 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
INDIA'S MAX HEALTHCARE INSTITUTE JUNE-QUARTER CONSOL PROFIT 2.4 BILLION RUPEES VERSUS 1.73 BILLION RUPEES
MAX HEALTHCARE INSTITUTE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 12.85 BILLION RUPEES VERSUS 10.67 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: MAXE.NS
(([email protected];))
Investors in UAE hospital chain Aster eye $300 mln India stake sale-sources
Aster investors eye selling 30% stake in India biz
Company has appointed investment bank Moelis for the deal
Talks come as investors attracted by India healthcare space
Adds context on industry, source feed on potential deal
By M. Sriram
MUMBAI, May 26 (Reuters) - Investors in Aster DM Healthcare ATRD.NS are in talks to sell a 30% stake in the company's India business for about $300 million, two sources with direct knowledge said, the latest potential deal in India's booming healthcare sector.
UAE-based and Mumbai-listed Aster runs 32 hospitals, 127 clinics and 521 pharmacies in India and the United Arab Emirates. The current talks are related to the India business and come just as Aster tries to demerge its Gulf business and sell a majority stake in that, Reuters reported last month.
Aster and its advisors have reached out to private equity giant KKR & Co Inc KKR.N and Max Healthcare Institute MAXE.NS - one of India's largest hospital chains - to hold preliminary talks to take up the investors' stake, the sources said.
Aster's investors considering the sale are Olympus Capital, which has a 19% stake in the company, and Mauritius-based investment firm Rimco, which holds an 12% stake.
Aster has appointed New York-based investment bank Moelis & Company to manage the deal, said the two sources, who declined to be named as the discussions are private.
Spokespersons for KKR and Olympus declined to comment, while Aster, Rimco, Moelis and Max did not respond to Reuters queries.
In India, private hospitals are much sought after and with federal spending on healthcare low, investors remain bullish on the sector's growth in a country of 1.4 billion people.
In April, Singapore-based Temasek spent $2 billion on a controlling stake in Manipal Health Enterprises. And last year, KKR clocked its biggest exit from India by selling its stake 27% stake in Max Healthcare for more than $1 billion.
Indian hospital chains have raised $2 billion from private equity funds this year, compared to last year's record funding of $3.2 billion, data from Dealogic showed.
"Compared to population healthcare is still underpenetrated in India. So as the country develops, investors see that as a big opportunity," one of the sources said.
Separately, as discussions progress for the 30% stake sale in the India business, Aster will gauge if other hospital chains are interested in taking a bigger stake in the healthcare operator, though the strategy has not been finalised, the first source said.
Aster is mainly present in the southern Indian states of Kerala and Andhra Pradesh. It competes with other large hospital chains including Fortis Healthcare FOHE.NS, Manipal Hospitals and Max, all of whom have raised funds from global investors in recent years.
"Aster is now the last remaining large hospital chain where private equity or strategic investors can come in. There aren't many other established chains," the first source said.
For the fiscal year ended March 31, Aster's revenue grew 16% to $1.46 billion, while its net profit stood at $51.36 million.
(Reporting by M. Sriram; editing by Conor Humphries and Jason Neely)
(([email protected];; Reuters Messaging: Twitter: @followthemani))
Aster investors eye selling 30% stake in India biz
Company has appointed investment bank Moelis for the deal
Talks come as investors attracted by India healthcare space
Adds context on industry, source feed on potential deal
By M. Sriram
MUMBAI, May 26 (Reuters) - Investors in Aster DM Healthcare ATRD.NS are in talks to sell a 30% stake in the company's India business for about $300 million, two sources with direct knowledge said, the latest potential deal in India's booming healthcare sector.
UAE-based and Mumbai-listed Aster runs 32 hospitals, 127 clinics and 521 pharmacies in India and the United Arab Emirates. The current talks are related to the India business and come just as Aster tries to demerge its Gulf business and sell a majority stake in that, Reuters reported last month.
Aster and its advisors have reached out to private equity giant KKR & Co Inc KKR.N and Max Healthcare Institute MAXE.NS - one of India's largest hospital chains - to hold preliminary talks to take up the investors' stake, the sources said.
Aster's investors considering the sale are Olympus Capital, which has a 19% stake in the company, and Mauritius-based investment firm Rimco, which holds an 12% stake.
Aster has appointed New York-based investment bank Moelis & Company to manage the deal, said the two sources, who declined to be named as the discussions are private.
Spokespersons for KKR and Olympus declined to comment, while Aster, Rimco, Moelis and Max did not respond to Reuters queries.
In India, private hospitals are much sought after and with federal spending on healthcare low, investors remain bullish on the sector's growth in a country of 1.4 billion people.
In April, Singapore-based Temasek spent $2 billion on a controlling stake in Manipal Health Enterprises. And last year, KKR clocked its biggest exit from India by selling its stake 27% stake in Max Healthcare for more than $1 billion.
Indian hospital chains have raised $2 billion from private equity funds this year, compared to last year's record funding of $3.2 billion, data from Dealogic showed.
"Compared to population healthcare is still underpenetrated in India. So as the country develops, investors see that as a big opportunity," one of the sources said.
Separately, as discussions progress for the 30% stake sale in the India business, Aster will gauge if other hospital chains are interested in taking a bigger stake in the healthcare operator, though the strategy has not been finalised, the first source said.
Aster is mainly present in the southern Indian states of Kerala and Andhra Pradesh. It competes with other large hospital chains including Fortis Healthcare FOHE.NS, Manipal Hospitals and Max, all of whom have raised funds from global investors in recent years.
"Aster is now the last remaining large hospital chain where private equity or strategic investors can come in. There aren't many other established chains," the first source said.
For the fiscal year ended March 31, Aster's revenue grew 16% to $1.46 billion, while its net profit stood at $51.36 million.
(Reporting by M. Sriram; editing by Conor Humphries and Jason Neely)
(([email protected];; Reuters Messaging: Twitter: @followthemani))
India's Max Healthcare Institute Ltd March-Quarter Consol Profit Rises
May 16 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MARCH-QUARTER CONSOL PROFIT 2.51 BILLION RUPEES VERSUS PROFIT 1.24 BILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 12.15 BILLION RUPEES VERSUS 9.37 BILLION RUPEES
DIVIDEND ONE RUPEE PER SHARE
Source text for Eikon: ID:nBSE6BLyWg
Further company coverage: MAXE.NS
(([email protected];))
May 16 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MARCH-QUARTER CONSOL PROFIT 2.51 BILLION RUPEES VERSUS PROFIT 1.24 BILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 12.15 BILLION RUPEES VERSUS 9.37 BILLION RUPEES
DIVIDEND ONE RUPEE PER SHARE
Source text for Eikon: ID:nBSE6BLyWg
Further company coverage: MAXE.NS
(([email protected];))
MEDIA-India's Max Healthcare sues TPG over Care Hospitals acquisition- ET
- Source link: (https://bityl.co/IT4y)
- Note: Reuters has not verified this story and does not vouch for its accuracy
(Bengaluru newsroom)
(([email protected]; +91 80 6749 1310;))
- Source link: (https://bityl.co/IT4y)
- Note: Reuters has not verified this story and does not vouch for its accuracy
(Bengaluru newsroom)
(([email protected]; +91 80 6749 1310;))
Max Healthcare Institute Files Petition Against Touch Healthcare, Quality Care India, Evercare Group Management
April 27 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
FILED PETITION IN COURT AGAINST TOUCH HEALTHCARE, QUALITY CARE INDIA, EVERCARE GROUP MANAGEMENT
PETITION SEEKS INTERIM MEASURES OF PROTECTION, PRESERVATION OF CONTRACTUAL RIGHTS AVAILABLE TO CO PRIOR TO ARBITRATION COMMENCEMENT
Source text for Eikon: ID:nNSE3x3f6R
Further company coverage: MAXE.NS
(([email protected];))
April 27 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
FILED PETITION IN COURT AGAINST TOUCH HEALTHCARE, QUALITY CARE INDIA, EVERCARE GROUP MANAGEMENT
PETITION SEEKS INTERIM MEASURES OF PROTECTION, PRESERVATION OF CONTRACTUAL RIGHTS AVAILABLE TO CO PRIOR TO ARBITRATION COMMENCEMENT
Source text for Eikon: ID:nNSE3x3f6R
Further company coverage: MAXE.NS
(([email protected];))
Max Healthcare Institute Completes Acquisition Of Additional 34% Stake In Eqova Healthcare
April 13 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MAX HEALTHCARE INSTITUTE LTD - COMPLETED ACQUISITION OF ADDITIONAL 34% STAKE IN EQOVA HEALTHCARE
Source text for Eikon: ID:nBSE3q6HCs
Further company coverage: MAXE.NS
(([email protected];))
April 13 (Reuters) - Max Healthcare Institute Ltd MAXE.NS:
MAX HEALTHCARE INSTITUTE LTD - COMPLETED ACQUISITION OF ADDITIONAL 34% STAKE IN EQOVA HEALTHCARE
Source text for Eikon: ID:nBSE3q6HCs
Further company coverage: MAXE.NS
(([email protected];))
Events:
Dividend
Dividend
More Large Cap Ideas
See similar 'Large' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Max Healthcare Inst do?
Max Healthcare Institute Limited is the second largest healthcare chain in India, offering a wide range of services across multiple specialties from its facilities in Delhi, NCR, Mohali, and Bathinda.
Who are the competitors of Max Healthcare Inst?
Max Healthcare Inst major competitors are Apollo Hospital Ent., Fortis Healthcare, Narayana Hrudayalay, Global Health, Krishna Inst.Medi, Aster DM Healthcare, RainbowChildrenS Med. Market Cap of Max Healthcare Inst is ₹1,09,697 Crs. While the median market cap of its peers are ₹34,262 Crs.
Is Max Healthcare Inst financially stable compared to its competitors?
Max Healthcare Inst seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Max Healthcare Inst pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Max Healthcare Inst latest dividend payout ratio is 13.78% and 3yr average dividend payout ratio is 11.29%
How has Max Healthcare Inst allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery
How strong is Max Healthcare Inst balance sheet?
Balance sheet of Max Healthcare Inst is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Max Healthcare Inst improving?
No, profit is decreasing. The profit of Max Healthcare Inst is ₹1,008 Crs for TTM, ₹1,058 Crs for Mar 2024 and ₹1,104 Crs for Mar 2023.
Is the debt of Max Healthcare Inst increasing or decreasing?
Yes, The debt of Max Healthcare Inst is increasing. Latest debt of Max Healthcare Inst is -₹99.45 Crs as of Sep-24. This is greater than Mar-24 when it was -₹1,040.74 Crs.
Is Max Healthcare Inst stock expensive?
Yes, Max Healthcare Inst is expensive. Latest PE of Max Healthcare Inst is 108, while 3 year average PE is 55.74. Also latest EV/EBITDA of Max Healthcare Inst is 63.77 while 3yr average is 49.34.
Has the share price of Max Healthcare Inst grown faster than its competition?
Max Healthcare Inst has given better returns compared to its competitors. Max Healthcare Inst has grown at ~57.77% over the last 2yrs while peers have grown at a median rate of 51.09%
Is the promoter bullish about Max Healthcare Inst?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Max Healthcare Inst is 23.74% and last quarter promoter holding is 23.74%.
Are mutual funds buying/selling Max Healthcare Inst?
The mutual fund holding of Max Healthcare Inst is increasing. The current mutual fund holding in Max Healthcare Inst is 13.38% while previous quarter holding is 11.72%.